Journal For Immunotherapy Of Cancer

Immune-checkpoint inhibitor-induced diarrhea and colitis in patients with advanced malignancies: retrospective review at MD Anderson

STAT3 antisense oligonucleotide AZD9150 in a subset of patients with heavily pretreated lymphoma: results of a phase 1b trial.

Monalizumab: inhibiting the novel immune checkpoint NKG2A

Targeting of M2-like tumor-associated macrophages with a melittin-based pro-apoptotic peptide

Collagen density regulates the activity of tumor-infiltrating T cells

Tumor mutation burden and circulating tumor DNA in combined CTLA-4 and PD-1 antibody therapy in metastatic melanoma - results of a prospective biomarker study

Infliximab associated with faster symptom resolution compared with corticosteroids alone for the management of immune-related enterocolitis

Stereotactic radiosurgery combined with nivolumab or Ipilimumab for patients with melanoma brain metastases: evaluation of brain control and toxicity

Effect of neoadjuvant chemotherapy on the immune microenvironment in non-small cell lung carcinomas as determined by multiplex immunofluorescence and image analysis approaches

Influenza vaccination of cancer patients during PD-1 blockade induces serological protection but may raise the risk for immune-related adverse events